Dr Reddy’s CFO Outlines Growth Plans Around Semaglutide and Abatacept
CFO MV Narasimham said growth plans include a semaglutide relaunch in Canada, a biosimilar pipeline, expansion in India and growth at Aurigene. The body is truncated after noting the move follows recent developments.